ICH E9 Statistical Principles for Clinical Trials

Target entity: ICH E9 Statistical Principles for Clinical Trials
Context triple: [ICH E8 General Considerations for Clinical Trials, relatedTo, ICH E9 Statistical Principles for Clinical Trials]

• A. ICH E8 General Considerations for Clinical Trials
  ICH E8 General Considerations for Clinical Trials is an international guideline that outlines fundamental principles and quality considerations for the design, conduct, and evaluation of clinical studies across all phases of drug development.
• B. ICH E6 Good Clinical Practice
  ICH E6 Good Clinical Practice is an international ethical and scientific quality standard that governs the design, conduct, recording, and reporting of clinical trials involving human subjects.
• C. ICH M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals
  ICH M3(R2) is an international guideline that harmonizes requirements for nonclinical safety studies needed to support the initiation and progression of human clinical trials and the marketing authorization of pharmaceuticals.
• D. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
  The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
• E. Statistics in Biopharmaceutical Research
  Statistics in Biopharmaceutical Research is a peer-reviewed journal focusing on the development and application of statistical methods in pharmaceutical, biotechnology, and medical product research.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target entity: ICH E9 Statistical Principles for Clinical Trials
Target entity description: ICH E9 Statistical Principles for Clinical Trials is an international guideline that defines key statistical concepts and methodologies to ensure the design, analysis, and interpretation of clinical trial data are scientifically sound and regulatory compliant.

• A. ICH E8 General Considerations for Clinical Trials
  ICH E8 General Considerations for Clinical Trials is an international guideline that outlines fundamental principles and quality considerations for the design, conduct, and evaluation of clinical studies across all phases of drug development.
• B. ICH E6 Good Clinical Practice
  ICH E6 Good Clinical Practice is an international ethical and scientific quality standard that governs the design, conduct, recording, and reporting of clinical trials involving human subjects.
• C. ICH M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals
  ICH M3(R2) is an international guideline that harmonizes requirements for nonclinical safety studies needed to support the initiation and progression of human clinical trials and the marketing authorization of pharmaceuticals.
• D. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
  The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
• E. Statistics in Biopharmaceutical Research
  Statistics in Biopharmaceutical Research is a peer-reviewed journal focusing on the development and application of statistical methods in pharmaceutical, biotechnology, and medical product research.
• F. None of above. chosen